Vascepa is an omega-3 fatty acid also known as icosapent ethyl. Doctors prescribe it to adults with certain conditions to lower their blood triglyceride levels and help reduce the risk of heart ...
Vascepa (icosapent ethyl) is a brand-name prescription medication. Doctors may prescribe it alongside dietary changes to reduce levels of triglyceride (a type of fat) in adults with severe ...
Jan 21 (Reuters) - Amarin Corp Plc's shares fell more than 26 percent after U.S. health regulators rejected a preset testing process that was critical to the company seeking broader use of its blood ...
Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...
Amarin's Vascepa drug had initial commercial success but is now facing steep revenue declines due to generic competition and limited U.S. market adoption. The company is running sizable losses, with ...
Vascepa is now available to more than 95% of Canadians who are eligible and covered by a public plan or private insurance Under the terms of the PLA, Vascepa will be reimbursed as an exception status ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results